TP53 and cancer: To support our hypothesis that loss of p53 function derepresses IRE1α expression, we analyzed nine wild-type p53- and 14 mutant p53-expressing human cancer cell lines to determine whether endogenous IRE1α expression levels were affected by p53 status.